Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1453 15 |
Ultima descărcare din IBN: 2023-12-19 23:36 |
SM ISO690:2012 PODGORNÎI, Ana, VALICA, Vladimir, MACAEV, Fliur, UNCU, Livia. Aspecte farmaceutice al isoconazolului. In: Analele Ştiinţifice ale USMF „N. Testemiţanu”, 2013, nr. 1(14), pp. 392-395. ISSN 1857-1719. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Analele Ştiinţifice ale USMF „N. Testemiţanu” | ||||||
Numărul 1(14) / 2013 / ISSN 1857-1719 | ||||||
|
||||||
Pag. 392-395 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
S-a studiat informaţiile publicate privind isoconazolul şi formele farmaceutice care sunt utilizate în tratamentul dermatomicozelor. Au fost evidenţiate direcţiile principale de optimizare a metodelor de analiză şi standardizare. |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-28258</cfResPublId> <cfResPublDate>2013-01-01</cfResPublDate> <cfVol>14</cfVol> <cfIssue>1</cfIssue> <cfStartPage>392</cfStartPage> <cfISSN>1857-1719</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/28258</cfURI> <cfTitle cfLangCode='RO' cfTrans='o'>Aspecte farmaceutice al isoconazolului</cfTitle> <cfAbstr cfLangCode='RO' cfTrans='o'>S-a studiat informaţiile publicate privind isoconazolul şi formele farmaceutice care sunt utilizate în tratamentul dermatomicozelor. Au fost evidenţiate direcţiile principale de optimizare a metodelor de analiză şi standardizare.</cfAbstr> <cfAbstr cfLangCode='EN' cfTrans='o'>It was researched the active substance isoconazol nitrate, its published informations. At present, there are many topical pharmaceutical forms with isoconazol that are used for treatment of dermatomycoses. It was highlighted the optimization perspectives of analytical methods and standardization.</cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2013-01-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2013-01-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-42675</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2013-01-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-11802</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2013-01-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-4389</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2013-01-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-12094</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2013-01-01T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-42675</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-42675-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2013-01-01T24:00:00</cfStartDate> <cfFamilyNames>Podgornîi</cfFamilyNames> <cfFirstNames>Ana</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-11802</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11802-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2013-01-01T24:00:00</cfStartDate> <cfFamilyNames>Valica</cfFamilyNames> <cfFirstNames>Vladimir</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-4389</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-4389-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2013-01-01T24:00:00</cfStartDate> <cfFamilyNames>Makaev</cfFamilyNames> <cfFirstNames>Fliur</cfFirstNames> <cfFamilyNames>Макаев</cfFamilyNames> <cfFirstNames>Флюр</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-12094</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-12094-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2013-01-01T24:00:00</cfStartDate> <cfFamilyNames>Uncu</cfFamilyNames> <cfFirstNames>Livia</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>